Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 3/20 | 0.58 |
| ▸ | TNKS | O95271 | 2/20 | 0.55 |
| ▸ | PARP1 | P09874 | 2/20 | 0.55 |
| ▸ | TNKS2 | Q9H2K2 | 2/20 | 0.55 |
| ▸ | PARP2 | Q9UGN5 | 2/20 | 0.55 |
| ▸ | SOAT1 | P35610 | 5/20 | 0.55 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.53 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5390175 | 0.86 | ALDH1A1 (0.47) | RAB9ATNKSPARP1TNKS2PARP2 | |
| SCHEMBL5390189 | 0.86 | ALDH1A1 (0.47) | RAB9ATNKSPARP1TNKS2PARP2 | |
| SCHEMBL1705553 | 0.84 | ALDH1A1 (0.52) | RAB9ATNKSPARP1TNKS2PARP2 | |
| SCHEMBL9514091 | 0.80 | RAB9A (0.74) | RAB9ATNKSPARP1TNKS2PARP2 | |
| SCHEMBL2775647 | 0.79 | RAB9A (0.52) | RAB9APARP1GRIN2BALDH1A1SMN1; SMN2 | |
| SCHEMBL13617010 | 0.79 | RAB9A (0.73) | RAB9ATNKSPARP1TNKS2PARP2 | |
| SCHEMBL6282065 | 0.78 | SOAT1 (0.55) | RAB9ASOAT1MAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL9512664 | 0.77 | RAB9A (0.78) | RAB9ATNKSPARP1TNKS2PARP2 | |
| SCHEMBL3844538 | 0.77 | RAB9A (0.70) | RAB9ATNKSPARP1TNKS2PARP2 | |
| SCHEMBL9513272 | 0.76 | RAB9A (0.76) | RAB9ATNKSPARP1TNKS2PARP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1460065-B1 | PROCESSES FOR PRODUCTION OF CYCLIC DIAMINE COMPOUNDS OR SALTS THEREOF | KOWA CO (JP) | 2012-12-05 | — | — | EP | disclosed |
| EP-1566381-B1 | PROCESS FOR PRODUCTION OF 1- 2-(BENZIMIDAZOL-2-YL- THIO)ETHYL PIPERAZINE OR SALTS THEREOF | KOWA CO (JP) | 2009-11-11 | — | — | EP | disclosed |
| US-7214796-B2 | Process for production of 1-[2-(benzimidazol-2-yl-thio)ethyl]piperazine or salts thereof | KOWA CO., LTD. (JP) | 2007-05-08 | — | — | US | disclosed |
| US-7214796-B2 | Process for production of 1-[2-(benzimidazol-2-yl-thio)ethyl]piperazine or salts thereof | KOWA CO., LTD. (JP) | 2007-05-08 | — | — | US | disclosed |
| US-20060035906-A1 | Process for production of 1-[2-(benzimidazol-2-yl- thio)ethy]piperazine or salts thereof | KOWA CO., LTD. AICHI, JAPAN | 2006-02-16 | — | — | US | disclosed |
| EP-1566381-A1 | PROCESS FOR PRODUCTION OF 1- 2-(BENZIMIDAZOL-2-YL- THIO)ETHYL ]PIPERAZINE OR SALTS THEREOF | Kowa Co., Ltd. (JP) | 2005-08-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060035906-A1 | Process for production of 1-[2-(benzimidazol-2-yl- thio)ethy]piperazine or salts thereof | SAT1, ACAT2, NAT1 | RAB9A 2124/4885TNKS 1407/4885PARP1 2321/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.